Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization

Alessandra SerraoDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Giuseppina LoglisciDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Adriano SalaroliDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Irene ZacheoDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Giuliana AlimenaDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Massimo BrecciaDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, ItalyCorrespondence[email protected]

References

Garcia-Manero G, Fenaux P.Hypomethylating agents and other novel strategies in myelodysplastic syndrome.J Clin Oncol2011;29:516–523.
PubMed Web of Science ®Google Scholar
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, .; International Vidaza High-Risk MDS Survival Study Group.Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.Lancet Oncol 2009;10:223–232.
PubMed Web of Science ®Google Scholar
Costa R, Abdulhaq H, Haq B, . Activity of azacitidine in chronic myelomonocytic leukemia. Cancer 2011;117:2690–2696.
PubMed Web of Science ®Google Scholar
Greco M, Criscuolo M, Fianchi L, . 5-Azacitidine in chronic myelomonocytic leukemia: case report and review of literature. Mediterr J Hematol Infect Dis 2011;3:e2011011.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date